Hesperidin RCT in MS
25 March 2026
Read original ↗
🅇 This trial is currently recruiting participants in the UK
Speak to your GP or specialist first. They can help you understand if you might be eligible and what taking part would involve.
🅇 This trial is currently recruiting volunteers
If you think you might be eligible, speak to your GP or specialist about this trial before applying.
Status
Recruiting
Phase
NA
Participants
ALL
Age Range
18 Years+
About This Trial
This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress.
Participants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.
Who Can Join?
Inclusion Criteria: * Diagnosis of Multiple Sclerosis, Aged 18 years or older. Exclusion Criteria: * Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.
⚠ Always speak to your doctor before applying to any clinical trial.